Analyst Price Target is $14.33
▲ +48.69% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Fennec Pharmaceuticals in the last 3 months. The average price target is $14.33, with a high forecast of $17.00 and a low forecast of $12.00. The average price target represents a 48.69% upside from the last price of $9.64.
Current Consensus is
The current consensus among 4 investment analysts is to buy stock in Fennec Pharmaceuticals. This Buy consensus rating has held steady for over two years.